Your browser doesn't support javascript.
loading
Management of medication overuse headache.
D'Amico, Domenico; Grazzi, Licia; Tepper, Stewart J.
Affiliation
  • D'Amico D; UOC Neuroalgologia, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
  • Grazzi L; UOC Neuroalgologia, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy. Electronic address: licia.grazzi@istituto-besta.it.
  • Tepper SJ; Neurology Department, Dartmouth-Hitchcock Medical Center, Lebanon, NH, United States.
Handb Clin Neurol ; 199: 277-299, 2024.
Article in En | MEDLINE | ID: mdl-38307652
ABSTRACT
Medication overuse headache (MOH) is a secondary headache characterized by frequent use of acute or symptomatic migraine medications at a sufficient frequency to transform patients from episodic to chronic migraine. MOH represents a significant medical problem, with a serious burden on patients' lives and on society as a whole. MOH patients often have additional comorbidities, and the clinical challenge of helping patients reduce acute medication use and revert to episodic headache can be marked. Treatment includes education and prevention; withdrawal programs; pharmacological prophylaxis; multidisciplinary therapies with behavioral and noninvasive neuromodulation options; and scheduled, frequent follow-up to prevent relapses. The advent of anti-CGRP therapy monoclonal antibodies may provide an alternative to more extensive programs for less complex patients. This review also provides guidance for which patients may benefit most from coordinated integrated programs.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: Headache Disorders, Secondary / Migraine Disorders Type of study: Guideline Limits: Humans Language: En Journal: Handb Clin Neurol Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: Headache Disorders, Secondary / Migraine Disorders Type of study: Guideline Limits: Humans Language: En Journal: Handb Clin Neurol Year: 2024 Document type: Article